Abstract
At least 25 types of degenerative diseases are thought to be caused by amyloid-beta, including Alzheimer’s. However, the exact mechanism of Alzheimer’s is still unknown. It has been shown that amphiphilic surfactants with varying tail lengths, PC20:0 and di-C7-PC, have differing effects on the structures of Aβ (1–40) and Aβ (1–42). This paper examines the interaction between these surfactants and peptides. The calculations were performed at concentrations lower than the critical micelle concentration. Four and 12 peptides of beta-amyloid isomers regimens were used for each simulation. Direct and indirect behavioral effects were extensively investigated. A number of critical analyses, including RMSD, ∆RMSF, Pi, and the hydration network, were performed to examine these peptides in the absence and presence of ligands. There can be a negative ∆RMSF for each sequence as a result of ligand or surfactant binding to that sequence; otherwise, the structure is partially or locally folded. Demonstrated that PC20:0 and di-C7-PC amphiphilic surfactants affect the aggregation of Aβ1–40 and Aβ1–42. The results of our simulations showed that the negative values of ΔRMSF match with some Pi > 1 values for both the hydrophobic and hydrophilic sides of ligands. Therefore, potential interactions between residual peptides and ligands were identified. A negative ΔRMSF did not match the Pi > 1 value, indicating the folding behavior of peptide residues.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Sch1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig1a_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig1b_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig4a_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig4b_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig5a_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig5b_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-023-02761-6/MediaObjects/13738_2023_2761_Fig8_HTML.png)
Similar content being viewed by others
References
Cuba’s aging and Alzheimer longitudinal study. SciELO Public Health, 2022
L. Gravitz, Drugs: a tangled web of targets. Nature 475, S9-11 (2011)
G. Yamin, K. Ono, M. Inayathullah, D.B. Teplow, Amyloid β-protein assembly as a therapeutic target of Alzheimer’s disease. Curr. Pharm. Des. 14, 3231–3246 (2008)
G. Chen, T. Xu, Y. Yan, Y. Zhou, Y. Jiang, K. Melcher, H. Eric Xu, Amyloid beta: structure, biology and structure-based therapeutic development. Nature 38, 1205–1235 (2017)
B. de Strooper, Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 90, 465–494 (2010)
M. Margittai, R. Langen, Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41, 265–297 (2008)
B. Cheng, H. Gong, H. Xiao, R.B. Petersen, L. Zheng, K. Huang, Inhibiting toxic aggregation of Amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochem. Biophys. Acta. 1830, 4860–4871 (2013)
D. J. Selkoe, in Synaptic Plasticity and the Mechanism of Alzheimer's Disease, ed. By Y. Christen (Springer, New York), 2008, p. 89
J.N. Gillet, From molecular dynamics to quantum mechanics of misfolded proteins and amyloid-like macroaggregates applied to neurodegenerative diseases. J. Mol. Graph. Model. 110, 108046 (2022)
D. Smith, R. Cappai, K. Barnham, The redox chemistry of the Alzheimer’s disease amyloid β peptide. Biochem. Biophys. Acta 1768, 1976–1990 (2007)
A. Rauk, The chemistry of Alzheimer’s disease. Chem. Soc. Rev. 38, 2698–2715 (2009)
S. Şahin, N. Dege, A newly synthesized small molecule: the evaluation against Alzheimer’s disease by in silico drug design and computational structure analysis methods. J. Mol. Struct. 1236, 130337 (2021)
W.I. Rosenblum, Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult. Neurobiol. Aging 35, 969–974 (2014)
J.H. Lee, N.H. Ahn, S. Bin Choi, Y. Kwon, S.H. Yang, Natural products targeting amyloid beta in Alzheimer’s disease. Int. J. Mol. Sci. 22, 1–17 (2021)
J. Mett, T. Hartmann, M.O.W. Grimm, the effects of glycerophospholipids and fatty acids on APP processing: implications for Alzheimer’s disease, ed by Handbook of Lipids in Human Function: Fatty Acids (2016), p. 377–421
M.O.W. Grimm, J. Mett, H.S. Grimm, T. Hartmann, App function and lipids: a bidirectional link. Front. Mol. Neurosci. 10, 63 (2017)
J. Mett, A.A. Lauer, D. Janitschke, L.V. Griebsch, E.L. Theiss, H.S. Grimm, H. Koivisto, H. Tanila, T. Hartmann, M.O.W. Grimm, Medium-chain length fatty acids enhance aβ degradation by affecting insulin-degrading enzyme. Cells 10, 2941 (2021)
S.S.S. Wang, Y.T. Chen, S.W. Chou, Inhibition of amyloid fibril formation of β-amyloid peptides via the amphiphilic surfactants. Biochim. Biophys. 1741, 307–313 (2005)
P.L. Rosen, J.N. Palmer, B.W. O’Malley, N.A. Cohen, Surfactants in the management of rhinopathologies. Am. J. Rhinol. Allergy 27, 177–180 (2013)
Y-M. Tricot, in Liquid Film Coating, ed. By S. F. Kistler and P. M. Schweizer (Springer, New York, 1997), p. 99
K. Jong, L. Grisanti, A. Hassanali, Hydrogen bond networks and hydrophobic effects in the amyloid β30-35 chain in water: a molecular dynamics study. J. Chem. Inf. Model. 57, 1548–1562 (2017)
M.H. Dehabadi, R. Firouzi, Constructing conformational library for amyloid-β42 dimers as the smallest toxic oligomers using two CHARMM force fields. J. Mol. Graph. Model. 115, 108207 (2022)
M. Badar, S. Shamsi, J. Ahmed, A. Alam, in Transdisciplinarity ed, By N. Rezaei (Springer, New York, 2022), p. 131
A. Rojas, N. Maisuradze, K. Kachlishvili, H.A. Scheraga, G.G. Maisuradze, Elucidating important sites and the mechanism for amyloid fibril formation by coarse-grained molecular dynamics. ACS Chem. Neurosci. 8, 201–209 (2017)
M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, E. Lindah, GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. Software X 1–2, 19–25 (2015)
A.K. Somavarapu, K.P. Kepp, The dependence of amyloid-β dynamics on protein force fields and water models. ChemPhysChem 16, 3278–3289 (2015)
B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, M. Karplus, CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4, 187–217 (1983)
V. Zoete, M.A. Cuendet, A. Grosdidier, O. Michielin, SwissParam: a fast force field generation tool for small organic molecules. J. Comput. Chem. 32, 2359–2368 (2011)
A. Ahmadzade, M. Bozorgmehr, E. Parvaee, The effect of sodium dodecyl sulfate concentration on the aggregation behavior of Aβ (1–42) peptide: molecular dynamics simulation approach. J. Mol. Liq. 303, 112651 (2020)
M.R. Bozorgmehr, M.R. Housaindokht, Effects of sodium dodecyl sulfate concentration on the structure of bovine carbonic anhydrase: molecular dynamics simulation approach. Rom. J. Biochem. 47, 3–15 (2010)
M. Ghoula, N. Janel, A.C. Camproux, G. Moroy, Exploring the structural rearrangements of the human insulin-degrading enzyme through molecular dynamics simulations. Int. J. Mol. Sci. 23, 1746 (2022)
N. Jeszenoi, I. Horváth, M. Bálint, D. van der Spoel, C. Hetényi, Mobility-based prediction of hydration structures of protein surfaces. Bioinformatics 31, 1959–1965 (2015)
H. Monhemi, M.R. Reza Housaindokht, A.A. Moosavi-Movahedi, M.R. Bozorgmehr, How a protein can remain stable in a solvent with high content of urea: insights from molecular dynamics simulation of Candida Antarctica lipase B in urea: choline chloride deep eutectic solvent. Phys. Chem. Chem. Phys. 16, 14882 (2014)
G.C. Justino, C.P. Nascimento, M.C. Justino, Molecular dynamics simulations and analysis for bioinformatics undergraduate students. Biochem. Mol. Biol. Educ. 49, 570–582 (2021)
Acknowledgements
We gratefully thank the Ferdowsi University of Mashhad for the support (Grant No. 3/55508).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abdulkareem, S.M., Housaindokht, M.R. & Bozorgmehr, M.R. The effect of PC20:0 and di-C7-PC amphiphilic surfactants on the aggregation of Aβ1–40 and Aβ1–42 using molecular dynamics simulation. J IRAN CHEM SOC 20, 1357–1370 (2023). https://doi.org/10.1007/s13738-023-02761-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-023-02761-6